Form 4: Shattuck Labs Director Receives Stock Option Grant

Director Clay B. Siegall was granted 81,000 stock options in Shattuck Labs, Inc. as part of a standard equity compensation arrangement.

Summary

• Director Clay B. Siegall received a grant of 81,000 stock options on May 29, 2026.
• The options have an exercise price of $5.95 per share.
• The options are set to expire on May 29, 2036.
• Vesting occurs on the earlier of the one-year anniversary of the grant date or immediately prior to the next annual meeting of stockholders.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation that carries no significant signal regarding company performance or outlook.

Positives

• Aligns director interests with long-term shareholder value through equity-based compensation.

Negatives

• Results in potential future dilution of existing shareholders upon exercise of the options.

Risks

• The value of the options is dependent on the future performance of the company's common stock price relative to the $5.95 exercise price.

Future Outlook

The options vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the next annual meeting of stockholders, contingent upon continued service.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are a standard corporate governance practice in the biotechnology sector to ensure board members maintain a vested interest in the company's long-term strategic success.

Comparison to Industry Standards

• The grant of stock options to directors is consistent with standard compensation packages for small-cap biotechnology firms.
• The vesting schedule is typical for annual director equity awards in the life sciences industry.

Stakeholder Impact

• Shareholders may experience minor dilution if these options are exercised in the future.

Next Steps

• Vesting of options on the earlier of May 29, 2027, or the next annual meeting of stockholders.

Key Dates

Keywords

Shattuck Labs, STTK, Director Compensation, Stock Options, Insider Transaction, Equity Grant